Notably, TPA treatment was found to stimulate IDO1 induction within dendritic cells in the regional lymph nodes, and genetic ablation of IDO1 substantially reduced the number of papillomas that formed in DMBA/TPA treated mice relative to their WT (wild type) counterparts (31). This evidence concerns the gene IDO1 and papilloma.